
News|Articles|May 1, 2002
Longer is better for thromboembolism prophylaxis after cancer surgery
Enoxaparin (Lovenox) is typically used during hospitalization after orthopedic or abdominal surgery. Recent studies of its use after orthopedic surgery have shown that extending administration of the low-molecular-weight heparin after hospital discharge significantly reduces the frequency of deep-vein thrombosis (DVT). A new study confirms this is also the case for abdominal surgery for cancer, which carries a high risk of this complication.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
HS patients on biosimilar adalimumab lose response faster than those on the original drug
2
Global MS analysis links disability burden to rising economic strain
3
CMS negotiates a 70% discount for Ozempic and Wegovy
4
Virtual care replaces, not adds, Medicare visits for health systems, analysis shows
5






















































